Search
for

    Sort by

    Research 91–120 of 114

    1. Systemic Circulating Leptin – Aiding New Dimension of Immune-Related Skin Carcinogenesis and Lipid Metabolism South East European Journal of Immunology · 2023 · 2 citations
    2. The Impact of Immune-Modifying Treatments for Skin Diseases on the Immune Response to COVID-19 Vaccines: a Narrative Review Current Dermatology Reports · 2022 · 2 citations
    3. Hair Loss Induced by Tumor Necrosis Factor Alpha Inhibitors Journal of clinical and investigative dermatology · 2014 · 2 citations
    4. Lipid nanocosmeceuticals: a novel approach to skin therapy for anti-aging and skin disorders Beni-Suef University Journal of Basic and Applied Sciences · 2025 · 1 citations
    5. Screening of dermatology drugs for aberrant use‐patterns: An application of epidemiologic estimates and measures of inequality in drug use British Journal of Clinical Pharmacology · 2024 · 1 citations
    6. Synchronous pancreas and gallbladder cancer with concomitant alopecia totalis Turkish Journal of Surgery · 2023 · 1 citations
    7. Drug Repurposing in Dermatology: Molecular Biology and Omics Approach IntechOpen eBooks · 2020 · 1 citations
    8. Acne-Associated Syndromes InTech eBooks · 2017 · 1 citations
    9. Hydrogels: current biomedical applications and future directions Molecular Biomedicine · 2026
    10. Systemic Lupus Erythematosus: What Every Clinician Needs to Know Mayo Clinic Proceedings · 2026
    11. Short-term Efficacy of Tofacitinib, a JAK Inhibitor, in IFIH1-related Aicardi-Goutières Syndrome European Journal of Medical Genetics · 2025
    12. Alopecia Areata: Features and Psychological Profiles (South American Perspectives) 2025
    13. The Role of Extracellular Vesicles in the Development and Treatment of Psoriasis: Narrative Review Pharmaceutics · 2024
    14. Clinicopathologic features, demographics, disease burden, and therapeutics in alopecic sarcoidosis: a case series and systematic review International Journal of Women’s Dermatology · 2024
    15. Childhood Systemic Lupus Erythematosus: Clinical and Immunologic Patterns in Mexican Children Cureus · 2024
    16. The Essence of Senior Residency: A Gateway to Professional Evolution Indian Journal of Postgraduate Dermatology · 2024
    17. Alopecia Areata: Features and Psychological Profiles (South American Perspectives) 2024
    18. A Real-World Study of Steroid-Free Monotherapy with Tofacitinib in Severe and Therapy-Recalcitrant Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Cases: A Retrospective Analysis Indian Dermatology Online Journal · 2023
    19. Application of the waiting time distribution in a nationwide screening of real‐world dermatology drug utilization for aberrant use patterns Pharmacoepidemiology and Drug Safety · 2023
    20. Madarosis and facial keratinaceous spines JAAD case reports · 2023
    21. Hair Disorders in Autoimmune Diseases Skin appendage disorders · 2023
    22. Tratamiento de la alopecia areata, un recorrido desde las opciones terapéuticas clásicas hasta los nuevos fármacos aparecidos en los últimos años Dermatology Online Journal · 2018
    23. ZALCITABINE 2004
    24. A NOVEL NANOGEL FORMULATION OF FINASTERIDE FOR TOPICAL TREATMENT OF ANDROGENETIC ALOPECIA: DESIGN, CHARACTERIZATION AND IN VITRO EVALUATION International Journal of Applied Pharmaceutics · 2021
    25. Leflunomide for the treatment of trichodysplasia spinulosa in a liver transplant recipient Transplant Infectious Disease · 2017 · 22 citations
    26. Alopecia universalis during treatment with leflunomide and adalimumab - Case report 2014 · 16 citations
    27. Recalcitrant alopecia areata responsive to leflunomide and anthralin—Potentially undiscovered JAK/STAT inhibitors? Pediatric dermatology · 2018 · 11 citations
    28. Alopecia areata secondary to the use of leflunomide in patients with rheumatoid arthritis: a case report and literature review Medwave · 2015 · 6 citations
    29. Late onset leflunomide-induced cutaneous ulcers in a seronegative arthritis patient: A case report SAGE Open Medical Case Reports · 2023 · 2 citations
    30. Leflunomide: an unlikely trigger and mechanistically a beneficial drug for alopecia areata Clinical Rheumatology · 2019 · 1 citations